Reaction
Malignant Peritoneal Neoplasm reporting signals
As of the last recalculation, Malignant Peritoneal Neoplasm appears in 586 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is NIRAPARIB (PRR 74.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Niraparib | 43 | 74.2 | 74.3 |
| Olaparib | 22 | 38.8 | 38.8 |
| Alpelisib | 8 | 33.0 | 33.1 |
| Polatuzumab Vedotin | 8 | 29.5 | 29.5 |
| Lanreotide Acetate | 4 | 18.2 | 18.2 |
| Regorafenib | 5 | 15.4 | 15.4 |
| Paclitaxel (Aibumin-Bound) | 32 | 14.6 | 14.6 |